News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
818,897 Results
Type
Article (74485)
Company Profile (644)
Press Release (743768)
Multimedia
Podcasts (127)
Webinars (14)
Section
Business (227530)
Career Advice (3721)
Deals (39316)
Drug Delivery (129)
Drug Development (89373)
Employer Resources (198)
FDA (17870)
Job Trends (17144)
News (387868)
Policy (38787)
Tag
Academia (3000)
Academic (1)
Accelerated approval (7)
Adcomms (30)
Allergies (96)
Alliances (56002)
ALS (107)
Alzheimer's disease (1512)
Antibody-drug conjugate (ADC) (166)
Approvals (17826)
Artificial intelligence (314)
Autoimmune disease (29)
Automation (17)
Bankruptcy (403)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (120)
Biotechnology (440)
Bladder cancer (88)
Brain cancer (33)
Breast cancer (322)
Cancer (2533)
Cardiovascular disease (213)
Career advice (3170)
Career pathing (34)
CAR-T (185)
Cell therapy (508)
Cervical cancer (22)
Clinical research (72361)
Collaboration (949)
Company closure (2)
Compensation (596)
Complete response letters (30)
COVID-19 (2871)
CRISPR (53)
C-suite (279)
Cystic fibrosis (110)
Data (2454)
Decentralized trials (2)
Denatured (43)
Depression (56)
Diabetes (307)
Diagnostics (6934)
Digital health (21)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (135)
Drug pricing (135)
Drug shortages (33)
Duchenne muscular dystrophy (108)
Earnings (94587)
Editorial (47)
Employer branding (25)
Employer resources (167)
Events (129289)
Executive appointments (803)
FDA (19343)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (847)
Gene editing (128)
Generative AI (29)
Gene therapy (379)
GLP-1 (868)
Government (5129)
Grass and pollen (6)
Guidances (174)
Healthcare (20877)
Huntington's disease (26)
IgA nephropathy (32)
Immunology and inflammation (158)
Indications (31)
Infectious disease (3035)
Inflammatory bowel disease (159)
Inflation Reduction Act (12)
Influenza (58)
Intellectual property (104)
Interviews (727)
IPO (17772)
IRA (51)
Job creations (4992)
Job search strategy (2593)
Kidney cancer (11)
Labor market (47)
Layoffs (567)
Leadership (24)
Legal (9919)
Liver cancer (82)
Lung cancer (355)
Lymphoma (169)
Machine learning (9)
Management (65)
Manufacturing (374)
MASH (87)
Medical device (14631)
Medtech (14636)
Mergers & acquisitions (22130)
Metabolic disorders (827)
Multiple sclerosis (92)
NASH (23)
Neurodegenerative disease (124)
Neuropsychiatric disorders (36)
Neuroscience (2154)
NextGen: Class of 2025 (7635)
Non-profit (5081)
Now hiring (42)
Obesity (442)
Opinion (276)
Ovarian cancer (85)
Pain (105)
Pancreatic cancer (91)
Parkinson's disease (169)
Partnered (23)
Patents (268)
Patient recruitment (124)
Peanut (51)
People (64162)
Pharmaceutical (133)
Pharmacy benefit managers (24)
Phase I (22375)
Phase II (31570)
Phase III (23783)
Pipeline (1519)
Policy (184)
Postmarket research (3256)
Preclinical (9883)
Press Release (72)
Prostate cancer (115)
Psychedelics (38)
Radiopharmaceuticals (270)
Rare diseases (443)
Real estate (7147)
Recruiting (75)
Regulatory (26134)
Reports (61)
Research institute (2656)
Resumes & cover letters (579)
Rett syndrome (6)
RNA editing (7)
RSV (50)
Schizophrenia (84)
Series A (148)
Series B (99)
Service/supplier (26)
Sickle cell disease (61)
Special edition (20)
Spinal muscular atrophy (165)
Sponsored (34)
Startups (4202)
State (2)
Stomach cancer (16)
Supply chain (75)
Tariffs (59)
The Weekly (82)
Vaccines (827)
Venture capitalists (45)
Weight loss (308)
Women's health (39)
Worklife (20)
Date
Today (193)
Last 7 days (942)
Last 30 days (3745)
Last 365 days (35042)
2025 (13461)
2024 (37898)
2023 (42567)
2022 (53926)
2021 (58723)
2020 (57663)
2019 (51302)
2018 (39084)
2017 (36830)
2016 (37739)
2015 (43730)
2014 (38413)
2013 (34388)
2012 (36287)
2011 (36403)
2010 (35833)
Location
Africa (1191)
Alabama (62)
Alaska (7)
Arizona (250)
Arkansas (14)
Asia (48713)
Australia (8377)
California (6894)
Canada (2154)
China (586)
Colorado (299)
Connecticut (312)
Delaware (171)
Europe (110141)
Florida (1009)
Georgia (234)
Hawaii (1)
Idaho (63)
Illinois (637)
India (30)
Indiana (348)
Iowa (13)
Japan (182)
Kansas (113)
Kentucky (28)
Louisiana (16)
Maine (72)
Maryland (1007)
Massachusetts (5257)
Michigan (256)
Minnesota (439)
Mississippi (2)
Missouri (93)
Montana (31)
Nebraska (26)
Nevada (72)
New Hampshire (69)
New Jersey (1923)
New Mexico (31)
New York (1930)
North Carolina (1161)
North Dakota (10)
Northern California (2979)
Ohio (229)
Oklahoma (15)
Oregon (46)
Pennsylvania (1497)
Puerto Rico (14)
Rhode Island (36)
South America (1565)
South Carolina (28)
South Dakota (1)
Southern California (2552)
Tennessee (111)
Texas (1024)
United States (26137)
Utah (202)
Virginia (181)
Washington D.C. (73)
Washington State (627)
West Virginia (3)
Wisconsin (73)
818,897 Results for "sumitomo pharmaceuticals co ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sumitomo Pharma America enters into a Cooperative Research and Development Agreement with the National Cancer Institute to Advance Clinical Understanding of Enzomenib
April 14, 2025
·
5 min read
Press Releases
Sumitomo Pharma America Presents New Data on Vibegron at the 2025 American Urological Association Annual Meeting
April 30, 2025
·
7 min read
Business
RevolKa Ltd.: Announcement of Milestone Achievement in the Collaborative Research with Sumitomo Pharma Co., Ltd.
RevolKa Ltd., a venture-backed biotech company providing a game-changing protein engineering technology platform is pleased to announce the successful completion of the collaborative drug discovery project with Sumitomo Pharma Co., Ltd. for rare diseases within the contractually agreed time frame.
June 23, 2023
·
3 min read
Press Releases
Merck Enters Exclusive License Agreement for HRS-5346, an Investigational Oral Lipoprotein(a) Inhibitor, for Cardiovascular Disease from Jiangsu Hengrui Pharmaceuticals Co., Ltd.
March 25, 2025
·
5 min read
BioMidwest
Sumitomo Chemical and Valent BioSciences Announce Divestiture of Pace International and Future Collaboration with AgroFresh Solutions in the Postharvest Solutions Space
Sumitomo Chemical Co., Ltd. and Valent BioSciences LLC announced that Pace International LLC and its operations overseas will become part of AgroFresh Solutions, Inc., a well-established leader in the postharvest solutions space.
March 27, 2024
·
5 min read
Press Releases
WORK Medical Technology Group LTD Announces Strategic Partnership with Shanghai Chartwell Medical Device Co., Ltd.
March 3, 2025
·
5 min read
Press Releases
Faron Pharmaceuticals Ltd: Grant of Options
May 15, 2025
·
5 min read
Press Releases
AriBio Co., Ltd. and Fujirebio Diagnostics, Inc. Announce Completion of Sample Set for the Strategic Partnership Implemented to Advance Biomarker Development for Alzheimer’s Disease and Neurodegeneration
May 9, 2025
·
3 min read
Genetown
Sumitomo Pharma Presents New Clinical Data on DSP-5336 at the European Hematology Association 2024 Congress
Sumitomo Pharma America, Inc. (SMPA) today announced the oral presentation of data from the ongoing Phase 1/2 first-in-human study of DSP-5336 in patients with relapsed or refractory acute leukemia at the European Hematology Association (EHA) 2024 Hybrid Congress.
June 14, 2024
·
7 min read
Business
Takeda, Astellas and Sumitomo Mitsui Banking Announce Master Agreement to Establish Joint Venture Company for Incubation of Early Drug Discovery Programs
Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., and Sumitomo Mitsui Banking Corporation announced that the three companies signed a master agreement on April 22, 2024, to establish a joint venture company.
April 22, 2024
·
5 min read
1 of 81,890
Next
